Antenatal glucocorticoid treatment attenuates immediate postnatal prostacyclin and thromboxane levels in plasma of very preterm lambs

Neonatology

Volumn 69, Issue 3, 1996, Pages 153-164

  Ibe, Basil O ^a   Okogbule Wonodi, Adora C ^a   Usha Raj, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA; Eicosanoids; Femoral artery; Mesenteric artery; Protein

Indexed keywords

BETAMETHASONE ACETATE PLUS BETAMETHASONE SODIUM PHOSPHATE; GLUCOCORTICOID; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; PROSTANOID; THROMBOXANE; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSISTED VENTILATION; BLOOD LEVEL; CONTROLLED STUDY; FEMORAL ARTERY; FETUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAMUSCULAR DRUG ADMINISTRATION; MESENTERIC ARTERY; NEWBORN; NONHUMAN; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANIMALS; ANIMALS, NEWBORN; BETAMETHASONE; CARBON DIOXIDE; DINOPROSTONE; EPOPROSTENOL; FEMALE; FEMORAL ARTERY; GESTATIONAL AGE; GLUCOCORTICOIDS; HYDROGEN-ION CONCENTRATION; MESENTERIC ARTERIES; OXYGEN; PREGNANCY; SHEEP; THROMBOXANE A2;

ANIMALIA; OVIS ARIES;

EID: 0029980631     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244291     Document Type: Article

References (26)

1. Crowley P. Chalmers I. Keirse M: The effect of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials. Br J Obslet Gynecol 1990:97:11-25.
2. Clyman RI, Ballard PL, Sniderman S. et al: Prenatal administration of betamethasone therapy on prevention of patent ductus arteriosus. J Pediatr 1981:98:123-128.
3. Bauer CR. Morrison JC. Poole WK. et al: Decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatries 1984:73:682-688.
4. Chen CM. Ikegami M. Ueda T, Polk DH, Jobe AH: Petal corticosteroid and Tj treatment effects on lung function of surfactant-treated preterm lambs. Am J Rcspir Crit Care Med 1995:151:21-26.
5. C'hcn CM. Ikegami M. Ueda T, Polk DH, Jobe AH: Exogenous surfactant function in very preterm lambs with and without fetal corticosteroid treatment. J Appl Physiol 1995:78: 955-960.
6. Jobe AH. Polk D. Ikegami M. Newnham J. Sly P. Kohen R: Lung responses to ultrasound guided fetal treatments with corticosteroid in preterm lambs. J Appl Physiol 1993; 75:2099-2105.
7. Ikegami M. Jacobs H. Jobe AH: Surfactant function in the respiratory distress syndrome. J Pediatr 1993: 102:443-447.
8. Campbell WB. Ojeda SR: Measurement of prostaglandins by radioimmunoassay. Methods Enzvmol 1987:141:323-341.
9. Ibe BO. Isenbcrg WB. Raj JU: Endogenous arachidonic acid metabolism by calcium ionophore A23187-stimulated lamb lungs: Effect of hypoxia. Am J Rcspir Cell Mol Biol 1991:4:379-385.
10. Filler SG. Ibe BO. Ibrahim AS, Ghannoum MA. Raj JU, Edwards JE Jr: Mechanisms bv which Candida albicans induces endothelial cell prostaglandin synthesis. Infect Immun 1994;62:1064-1069.
11. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protcin-dye binding. Anal Biochent 1976:72: 248-254.
12. Hill BT. Whatley S: A simple, rapid microassay for DNA. FEBS Lett 1975:56:20-23.
13. Moncada S: Prostacyclin and arterial wall biology. Arteriosclerosis 1982:2:193-207.
14. Brigham K.L: Metabolism of arachi-donic acid in experimental lung vascular injury. Fed Proc 1985:44:43-45.
15. Revtyak GE, Hughes MJ, Johnson AR, Campbell WB: Histamine stimulation of prostaglandin synthesis in human endothelial cells. Am J Physiol 1988:255:C214-C225.
16. Stein HM. Oyama K. Martinez A. Chappell AM. Buhl E. Blount L. Padbury JF: Effects of corticosteroid in preterm sheep on adaptation and sympathoadrenal mechanism at birth. Am J Physiol 1993:264:E763-E769.
17. Fitzgerald DJ. Roy L. Catella F. Fitzgerald GA: Platelet activation in unstable coronary disease. N Engl J Med 1986:315:983-989.
18. Patrono C. Ciabattoni G. Patro-gnani P. Filabozzi P. Pinea E. Salta MA. Va Donne D. Cinotti GA. Pugliese F. Picrucci A. Simonelli BM: Evidence for renal origin of urinary thromboxane B; in health and disease. Adv Prostaglandin Thromboxane Leukot Res 1988:11:493-498.
19. Neri-Sereri GG. Masotti G. Poggessi L. et al: Release of prostacyclin into blood stream and its exhaustion in humans after local blood flow changes (ischemia and venous stasis). Thromb Res 1980:17:197-202.
20. De Caterina R. Wekslcr BB: Modulation of arachidonie acid metabolism in human endothelial cells by-glucocorticoids. Thromb Haemost 1986:55:369-374.
21. Bailey JM. Makheja AN. Pash J. Verma M: Corticosteroids suppress cyclooxygenase messenger RNA level and prostanoid synthesis in cultured vascular cells. Biochem Bio-phys ResCommun 1988:157 1159-1163.
22. Davidson FF, Dennis EA, Powell M, Glenncv JR: Inhibition of phospholipase A; by ‘lipocortins' and calpactins. An effect of binding to substrate phospholipids. J Biol Client 1987:262:1699-1705.
23. Flower RJ: Lipocortin and the mechanism of action of glucocorticoids. Br J Pharmacol 1988:94:987-1015.
24. Aarsman AJ. Mynbeek G. van den Bosch H. Rothhut B. Prieur B. Co-nicra C. Jordan L. Russo-Marie F: Lipocortin inhibition of extracellular phospholipase A; is substrate concentration dependent. FEBS Lett 1987;219:176-180.
25. Landers JP. Spelsberg TC: New concepts in steroid hormone action: Transcription factors, proto-oncogenes. and the cascade model for steroid regulation of gene expression. Crit Rev Eukaryotic Gene Express 1992:2:19-63.
26. Pearce WJ. Hull AD. Long DM. Longo LD: Developmental changes in ovine cerebral artery composition and reactivity. Am J Physiol 1991: 261.R458-R465.